Skip to content

ImPACT

by ImPACT Applications, Inc.

Ref ImPACT

ImPACT is a medical device (EU MDR Class I; FDA Class II; FDA product code POM, Computerized Cognitive Assessment Aid For Concussion) made by ImPACT Applications, Inc., registered in EUDAMED on 21 Dec 2024 (Basic UDI-DI 08641270003impactcognit9L), cleared under FDA 510(k) K181223 on 20 Oct 2018 (1 earlier submission) and granted FDA De Novo DEN150037 on 22 Aug 2016 and in 1 more registry, active as of 24 Oct 2026.

Active European Union and United States. Also listed in GUDID (US), partly in commercial distribution.

CE MDR 510(k) De Novo

Valid until

No date given

CE: no date in EUDAMED. FDA: not time-limited

FDA recalls

None found

in data synced 24 Oct 2026

Documents

None linked in EUDAMED

A group certificate may exist

Trust

Unverified

Source EUDAMED, FDA 510(k), GUDID, synced 24 Oct 2026.

Regulatory status

as of registry sync 24 Oct 2026

RegionAuthorizationNumberDateStatus
European UnionCE/MDR EUDAMED Number08641270003impactcognit9L Basic UDI-DI 00864127000349UDI-DIDate21 Dec 2024RegisteredStatusActive
United StatesGUDID listing GUDID Number00864127000349 UDI-DI Date27 Feb 2021ListedStatusListed GUDID: 1 of 2 UDI-DIs in commercial distribution
United StatesFDA 510(k) 510(k) NumberK181223 Date20 Oct 2018IssuedStatusActive
United StatesFDA De NovoDENG GUDID from GUDID De Novo granted · Direct NumberDEN150037 Date22 Aug 2016DecidedStatusActive

Official records

From the FDA record

UDI-DI 00864127000349
ImPACT is intended for use as a computer-based neurocognitive test battery to aid in the assessment and management of concussion. ImPACT is a neurocognitive test battery that provides healthcare professionals with objective measure of neurocognitive functioning as an assessment aid and in the management of concussion in individuals ages 12-80.
UDI-DI 00864127000301
ImPACT is intended for use as a computer-based neurocognitive test battery to aid in the assessment and management of concussion. ImPACT is a neurocognitive test battery that provides healthcare professionals with objective measure of neurocognitive functioning as an assessment aid and in the management of concussion in individuals ages 12-59.

From the GUDID record (AccessGUDID), as read on 30 May 2026, as the labeller entered it.

Across registries

4 registries list this device

  • EUDAMED Basic UDI-DI 08641270003impactcognit9L registered 21 Dec 2024 Active
  • FDA 510(k) K181223 decided 20 Oct 2018 Active· +1 more in the status table
  • FDA De Novo DEN150037 decided 22 Aug 2016 Active
  • FDA GUDID UDI-DI 00864127000349 listed 27 Feb 2021 Listed

Timeline

5 dated events

  1. Granted FDA De Novo DEN150037
  2. Cleared FDA 510(k) K170209
  3. Cleared FDA 510(k) K181223
  4. Listed FDA GUDID 00864127000349
  5. Registered EUDAMED 08641270003impactcognit9L

Coverage

2 jurisdictions

United States of AmericaSwedenFinlandLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaAustriaHungaryRomaniaSloveniaBulgariaPortugalSpainItalyCroatiaGreeceMaltaCyprus
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered
  • United States FDA 510(k), FDA De Novo Active
  • European Union CE/MDR Active

Specification

EUDAMED · 510(k) · GUDID

Trade name
ImPACT EUDAMEDGUDID
ImPACT Version 4 GUDID
Generic name
Cognitive assessment software
Cause-and-effect assistive training device
Model / reference
ImPACT, 4
Primary DI / UDI-DI
00864127000349, 00864127000301
Basic UDI-DI
08641270003impactcognit9L
De Novo Number
FDA product code
POM
EMDN code
Z12109092 Various neurology and neurosurgery instruments - medical device software
GMDN term
Cognitive assessment software
Cause-and-effect assistive training device
Device class
Class I EUDAMED
Class II GUDID
Regulation number
882.1471
System or procedure pack
System which is a device in itself
EU registration type
Standard device
EU market of registration
Ireland
GUDID distribution status
In Commercial Distribution (UDI-DI 00864127000349)
Not in Commercial Distribution (UDI-DI 00864127000301)

Truth per registry

2 sources · 1 field differs

FieldEUDAMEDGUDID
Device classEUDAMED
Class I
GUDID
Class II

Device class is stated on each registry's own scale: Class I in the EU (EUDAMED), Class II in the US (FDA GUDID). EU and US classes are different schemes, so this is not a disagreement.

Manufacturer details

EUDAMED SRN
US-MF-000002776
Authorised representative
Advena Limited MT-AR-000000234

Similar devices in this category

Other devices filed under VARIOUS NEUROLOGY AND NEUROSURGERY INSTRUMENTS - MEDICAL DEVICE SOFTWARE.

Other devices from ImPACT Applications, Inc.

See all devices from ImPACT Applications, Inc. →

Properties

  • Prescription use
Other properties (24, all answered No)